Non-muscle invasive bladder cancer recurrences in patients managed with trimodal therapy: Conservative or radical treatment? by K.A. Ajib, M.B. Berjaoui, J.O.H. Caceres, M.C. Tjong, G. Nason, A. Erlich, S. Sridhar, N.E. Fleshner, A. R. Zlotta, C. Catton, A. Berlin, P. Chung, G.S. Kulkarni

Get full text

Differences in contemporary biopsy Gleason score distribution in large cohorts of men diagnosed with prostate cancer from China and Canada by L. Dong, W. Xu, D. Woon, C. Kuk, Y. Zhu, A. Erlich, Z. Ma, O. Shi, B. Dong, M. Nesbitt, S.V. Carlsson, G. Kulkarni, R. Hamilton, A. Finelli, N.E. Fleshner, A. Toi, T.H. Van Der Kwast, W. Xue, A.R Zlotta

Get full text

Development, multi-institutional external validation, and algorithmic audit of SEPERA – An artificial intelligence-based side-specific extra-prostatic extension risk assessment too... by J.C.C. Kwong, K. Adree, E. Meng, N. Taylor, C. Kuk, N. Perlis, G.S. Kulkarni, R.J. Hamilton, N.E. Fleshner, A. Finelli, T.H. Van Der Kwast, A. Ali, M. Jamal, F. Papanikolaou, T. Short, J. Srigley, V. Colinet, A. Peltier, R. Diamand, Y. Lefebvre, Q. Mandoorah, R. Sanchez-Salas, P. Macek, X. Cathelineau, M. Eklund, A.E.W. Johnson, A. Feifer, A.R. Zlotta

Get full text